再鼎医药(ZLAB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ZLAB 再鼎医药

盘后交易 04-30 16:31:57 EDT

31.69

-0.15

-0.47%

盘后31.38

-0.31-0.98%

16:09 EDT

最高32.16	最低31.27	成交量63.48万
今开31.75	昨收31.84	日振幅2.80%
总市值34.81亿	流通市值31.81亿	总股本1.10亿
成交额2,010万	换手率0.63%	流通股本1.00亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ZLAB","market":"US","secType":"STK","nameCN":"再鼎医药","latestPrice":31.69,"timestamp":1746043200000,"preClose":31.84,"halted":0,"volume":634760,"hourTrading":{"tag":"盘后","latestPrice":31.38,"preClose":31.69,"latestTime":"16:09 EDT","volume":5834,"amount":184879.150798,"timestamp":1746043740763},"delay":0,"floatShares":100392399,"shares":109837154,"eps":-2.59837,"marketStatus":"盘后交易","change":-0.15,"latestTime":"04-30 16:31:57 EDT","open":31.75,"high":32.16,"low":31.27,"amount":20103954.31716,"amplitude":0.027952,"askPrice":32.3,"askSize":52,"bidPrice":31.29,"bidSize":50,"shortable":3,"etf":0,"ttmEps":-2.59837,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1746057600000},"marketStatusCode":4,"adr":1,"adrRate":10,"listingDate":1505880000000,"exchange":"NASDAQ","adjPreClose":31.84,"preHourTrading":{"tag":"盘前","latestPrice":32.5,"preClose":31.84,"latestTime":"09:13 EDT","volume":432,"amount":13808.839824,"timestamp":1746018786282},"postHourTrading":{"tag":"盘后","latestPrice":31.38,"preClose":31.69,"latestTime":"16:09 EDT","volume":5834,"amount":184879.150798,"timestamp":1746043740763},"volumeRatio":0.537732,"impliedVol":0.7512,"impliedVolPercentile":0.64},"requestUrl":"/m/hq/s/ZLAB/wiki","defaultTab":"wiki","newsList":[{"id":"2531465721","title":"再鼎医药4月29日成交额为3544.17万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531465721","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531465721?lang=zh_cn&edition=full","pubTime":"2025-04-30 11:23","pubTimestamp":1745983399,"startTime":"0","endTime":"0","summary":"美东时间2025年4月29日，再鼎医药成交额为3544.17万美元，成交额较昨日减少5.20%，当日成交量为111.91万股。再鼎医药于2025年4月29日跌1.82%，报31.84美元，该股过去5个交易日跌2.12%，年初至今涨21.57%，过去60日涨17.1%。公司的专利候选药物产品管线包括 ZL-1218  实体瘤、ZL-1310  ES-SCLC 其他 NECs、ZL-6301  实体瘤、ZL6201  实体瘤。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430112320a6ce398a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430112320a6ce398a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","BK4588","ZLAB","LU2488822045.USD","BK4139","BK4526","BK4531","BK4585"],"gpt_icon":0},{"id":"2531624849","title":"再鼎医药4月28日成交额为3738.43万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531624849","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531624849?lang=zh_cn&edition=full","pubTime":"2025-04-29 11:19","pubTimestamp":1745896769,"startTime":"0","endTime":"0","summary":"美东时间2025年4月28日，再鼎医药成交额为3738.43万美元，成交额较昨日减少30.29%，当日成交量为115.26万股。再鼎医药于2025年4月28日涨1.34%，报32.43美元，该股过去5个交易日涨9.16%，年初至今涨23.83%，过去60日涨16.49%。公司的专利候选药物产品管线包括 ZL-1218  实体瘤、ZL-1310  ES-SCLC 其他 NECs、ZL-6301  实体瘤、ZL6201  实体瘤。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429111930a46b631d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429111930a46b631d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4526","ZLAB","BK4531","BK4139","BK4548","LU2488822045.USD","BK4588"],"gpt_icon":0},{"id":"2530528494","title":"港股生物技术股多数走低，康方生物跌超12%，云康集团跌超6%，思路迪医药股份、再鼎医药跌超4%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2530528494","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530528494?lang=zh_cn&edition=full","pubTime":"2025-04-28 10:14","pubTimestamp":1745806482,"startTime":"0","endTime":"0","summary":"港股生物技术股多数走低，康方生物跌超12%，云康集团跌超6%，思路迪医药股份、再鼎医药跌超4%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/28101449938498.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1219","BK4531","HSCEI","IE00BPRC5H50.USD","IE00B543WZ88.USD","BK1574","09926","LU0348784397.USD","LU1720050803.USD","BK4585","YANG","LU0348783233.USD","02325","LU2488822045.USD","BK1161","BK1588","ZLAB","BK4588","IE00B5MMRT66.SGD","LU0417516571.SGD","BK4526","HSTECH","BK4139","BK4614","LU1794554557.SGD","09688","01244","BK4548"],"gpt_icon":0},{"id":"2530499592","title":"【港股医药股走低 康方生物跌超15%】截至发稿，康方生物(09926.HK)跌15.07%、宜明昂科-B(01541.HK)跌9.75%、再鼎医药(09688.HK)跌6.43%、加科思-B(01167.HK)跌5.37%、腾盛博药-B(02137.HK)跌5%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2530499592","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530499592?lang=zh_cn&edition=full","pubTime":"2025-04-28 09:40","pubTimestamp":1745804429,"startTime":"0","endTime":"0","summary":"截至发稿，康方生物(09926.HK)跌15.07%、宜明昂科-B(01541.HK)跌9.75%、再鼎医药(09688.HK)跌6.43%、加科思-B(01167.HK)跌5.37%、腾盛博药-B(02137.HK)跌5%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/28094049937146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01167","ZLAB","LU1794554557.SGD","159718","LU1720050803.USD","BK1587","BK4139","01541","LU0348784397.USD","BK1161","09688","BK1588","BK4548","02137","IE00B543WZ88.USD","BK4585","BK4531","LU0348783233.USD","BK1574","LU2488822045.USD","BK4588","09926","BK4526","IE00B5MMRT66.SGD","LU0417516571.SGD","IE00BPRC5H50.USD"],"gpt_icon":0},{"id":"2530543114","title":"再鼎医药4月25日成交额为5362.84万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530543114","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530543114?lang=zh_cn&edition=full","pubTime":"2025-04-26 11:16","pubTimestamp":1745637363,"startTime":"0","endTime":"0","summary":"美东时间2025年4月25日，再鼎医药成交额为5362.84万美元，成交额较昨日增加86.67%，当日成交量为167.14万股。再鼎医药于2025年4月25日跌5.33%，报32.0美元，该股过去5个交易日涨10.96%，年初至今涨22.18%，过去60日涨17.47%。公司的专利候选药物产品管线包括 ZL-1218  实体瘤、ZL-1310  ES-SCLC 其他 NECs、ZL-6301  实体瘤、ZL6201  实体瘤。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426111611a6c8e4b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426111611a6c8e4b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZLAB","BK4588","BK4548","LU2488822045.USD","BK4585","BK4531","BK4526"],"gpt_icon":0},{"id":"2530345150","title":"再鼎医药盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530345150","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530345150?lang=zh_cn&edition=full","pubTime":"2025-04-26 00:14","pubTimestamp":1745597643,"startTime":"0","endTime":"0","summary":"北京时间2025年04月26日00时14分，再鼎医药股票出现波动，股价急速下挫5.00%。截至发稿，该股报32.11美元/股，成交量38.4047万股，换手率0.35%，振幅3.28%。再鼎医药股票所在的生物技术行业中，整体跌幅为0.25%。其相关个股中，Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Jaguar Health, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Azitra Inc、Tnf Pharmaceuticals, Inc.、Briacell Therapeutics Corp.较为活跃，换手率分别为266.72%、232.67%、115.66%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Coeptis Therapeutics Holdings, Inc.，振幅分别为90.48%、48.68%、38.57%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426001403a4670627&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426001403a4670627&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZLAB","BK4526","BK4531","LU2488822045.USD","BK4588","BK4548","BK4139","BK4585"],"gpt_icon":0},{"id":"2529722612","title":"再鼎医药4月23日成交额为3735.08万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529722612","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529722612?lang=zh_cn&edition=full","pubTime":"2025-04-24 11:16","pubTimestamp":1745464600,"startTime":"0","endTime":"0","summary":"美东时间2025年4月23日，再鼎医药成交额为3735.08万美元，成交额较昨日减少8.69%，当日成交量为110.59万股。再鼎医药于2025年4月23日涨3.35%，报33.62美元，该股过去5个交易日涨10.66%，年初至今涨28.37%，过去60日涨25.26%。公司的专利候选药物产品管线包括 ZL-1218  实体瘤、ZL-1310  ES-SCLC 其他 NECs、ZL-6301  实体瘤、ZL6201  实体瘤。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424111646a464bc3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424111646a464bc3b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","BK4139","BK4526","LU2488822045.USD","BK4585","BK4531","BK4588","ZLAB"],"gpt_icon":0},{"id":"2529768031","title":"再鼎医药盘中异动 大幅上涨5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529768031","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529768031?lang=zh_cn&edition=full","pubTime":"2025-04-23 22:07","pubTimestamp":1745417227,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日22时07分，再鼎医药股票出现波动，股价急速上涨5.32%。截至发稿，该股报34.26美元/股，成交量16.2764万股，换手率0.15%，振幅1.94%。再鼎医药股票所在的生物技术行业中，整体涨幅为1.11%。其相关个股中，Protagenic Therapeutics Inc C/Wts 26/04/2026 、Ensysce Biosciences, Inc.、Silexion Therapeutics Corp涨幅较大，Ensysce Biosciences, Inc.、Silexion Therapeutics Corp、Plus Therapeutics, Inc.较为活跃，换手率分别为5024.32%、284.84%、54.97%，振幅较大的相关个股有Humacyte Inc C/Wts 27/08/2026 、Silexion Therapeutics Corp、Ensysce Biosciences, Inc.，振幅分别为115.77%、69.86%、69.51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423220707aa2c78f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423220707aa2c78f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4531","ZLAB","BK4548","LU2488822045.USD","BK4585","BK4139","BK4526"],"gpt_icon":0},{"id":"2529593121","title":"再鼎医药4月22日发行新股200万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2529593121","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529593121?lang=zh_cn&edition=full","pubTime":"2025-04-23 08:22","pubTimestamp":1745367720,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　再鼎医药（09688）发布公告，于2025年4月22日因兑现按先前披露的条款（1）归属根据 2017，2022及2024年股权激励计划所授出的非期权奖励，及（2）如适用，行使根据2015，2017，2022及2024年股权激励计划所授出的购股权发行新股200万股。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-04-23/doc-ineuccea3438380.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["ZLAB","BK4585","BK4139","09688","BK4588","BK4548","BK4526","LU2488822045.USD","BK1588","BK1574","BK1161","BK4531"],"gpt_icon":0},{"id":"2529743585","title":"再鼎医药盘中异动 早盘股价大涨7.57%报31.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529743585","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529743585?lang=zh_cn&edition=full","pubTime":"2025-04-22 21:32","pubTimestamp":1745328729,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日21时32分，再鼎医药股票出现异动，股价急速上涨7.57%。截至发稿，该股报31.96美元/股，成交量6.2727万股，换手率0.06%，振幅3.33%。再鼎医药股票所在的生物技术行业中，整体涨幅为0.97%。其相关个股中，阿诺医药、60 Degrees Pharmaceuticals, Inc.、Ibio, Inc.涨幅较大，Ocean Biomedical, Inc.、Lipella Pharmaceuticals Inc.、Ibio, Inc.较为活跃，换手率分别为160.60%、94.76%、34.57%，振幅较大的相关个股有Vincerx Pharma, Inc.、Revelation Biosciences, Inc.、60 Degrees Pharmaceuticals, Inc.，振幅分别为18.75%、9.55%、9.15%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422213209a46289bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422213209a46289bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK4139","ZLAB","BK4588","BK4531","BK4548","BK4526","BK4585"],"gpt_icon":0},{"id":"2529630675","title":"再鼎医药(09688)4月22日发行新股200万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2529630675","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529630675?lang=zh_cn&edition=full","pubTime":"2025-04-22 20:21","pubTimestamp":1745324463,"startTime":"0","endTime":"0","summary":"智通财经APP讯，再鼎医药(09688)发布公告，于2025年4月22日因兑现按先前披露的条款(1)归属根据 2017，2022及2024年股权激励计划所授出的非期权奖励，及(2)如适用，行使根据2015，2017，2022及2024年股权激励计划所授出的购股权发行新股200万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282505.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","BK4526","ZLAB","BK4531","BK1588","BK4139","09688","BK4548","BK4588","BK1574","LU2488822045.USD","BK1161"],"gpt_icon":0},{"id":"2529943371","title":"再鼎医药(ZLAB)盘前涨超7% 瑞普替尼新适应症上市申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2529943371","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529943371?lang=zh_cn&edition=full","pubTime":"2025-04-22 18:52","pubTimestamp":1745319158,"startTime":"0","endTime":"0","summary":"金吾财讯 | 再鼎医药(ZLAB)盘前涨超7%，截至发稿，报31.87美元。消息面上，4月21日，再鼎医药宣布，国家药品监督管理局（NMPA）已受理瑞普替尼（repotrectinib）的补充新药上市申请（sNDA），用于治疗携带神经营养酪氨酸受体激酶（NTRK）基因融合的实体瘤成人患者，该类患者为局部晚期、转移性，或手术切除可能导致严重并发症的患者，且这些患者在接受既往治疗后出现疾病进展，或缺乏有效的治疗方案选择。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250107/OWU4OGExOTI2NzgyMTc2NjE0.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/OWU4OGExOTI2NzgyMTc2NjE0.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"287723","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4526","ZLAB","BK4531","BK1588","BK4139","09688","BK4548","BK4588","BK1574","LU2488822045.USD","BK1161"],"gpt_icon":0},{"id":"2529345581","title":"港股异动 | 再鼎医药(09688)涨超7% 瑞普替尼新适应症上市申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2529345581","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529345581?lang=zh_cn&edition=full","pubTime":"2025-04-22 15:34","pubTimestamp":1745307273,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，再鼎医药涨超7%，截至发稿，涨7.02%，报24.4港元，成交额2.79亿港元。另外，公司合作伙伴argenx近日宣布，艾加莫德预充针皮下注射剂型获美国FDA批准上市。据悉，目前在国内，艾加莫德已有静脉输注和皮下注射2种给药方式。再鼎医药将于2025年在国内递交艾加莫德预充式皮下注射剂型的上市申请。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282177.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1588","09688","ZLAB","BK4531","BK4585","BK4526","LU2488822045.USD","BK4588","BK4548","BK1574","BK4139"],"gpt_icon":0},{"id":"2529941963","title":"再鼎医药4月21日成交额为2048.03万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529941963","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529941963?lang=zh_cn&edition=full","pubTime":"2025-04-22 11:18","pubTimestamp":1745291917,"startTime":"0","endTime":"0","summary":"美东时间2025年4月21日，再鼎医药成交额为2048.03万美元，成交额较昨日减少8.55%，当日成交量为69.61万股。再鼎医药于2025年4月21日涨3.02%，报29.71美元，该股过去5个交易日涨0.58%，年初至今涨13.44%，过去60日涨15.87%。公司的专利候选药物产品管线包括 ZL-1218  实体瘤、ZL-1310  ES-SCLC 其他 NECs、ZL-6301  实体瘤、ZL6201  实体瘤。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422111838a461e05a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422111838a461e05a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZLAB","BK4526","BK4531","LU2488822045.USD","BK4588","BK4548","BK4139","BK4585"],"gpt_icon":0},{"id":"2528658081","title":"再鼎医药4月17日成交额为2239.40万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528658081","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528658081?lang=zh_cn&edition=full","pubTime":"2025-04-18 11:23","pubTimestamp":1744946594,"startTime":"0","endTime":"0","summary":"美东时间2025年4月17日，再鼎医药成交额为2239.40万美元，成交额较昨日减少40.04%，当日成交量为77.85万股。再鼎医药于2025年4月17日跌0.33%，报28.84美元，该股过去5个交易日涨18.59%，年初至今涨10.12%，过去60日涨8.3%。公司的专利候选药物产品管线包括 ZL-1218  实体瘤、ZL-1310  ES-SCLC 其他 NECs、ZL-6301  实体瘤、ZL6201  实体瘤。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418112315a45d5d1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418112315a45d5d1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4531","BK4585","BK4139","LU2488822045.USD","ZLAB","BK4548","BK4588","BK4526"],"gpt_icon":1},{"id":"2528781917","title":"中金：维持再鼎医药(09688)跑赢行业评级 目标价34.41港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528781917","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528781917?lang=zh_cn&edition=full","pubTime":"2025-04-17 09:15","pubTimestamp":1744852527,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中金发布研报称，维持再鼎医药2025年和2026年盈利预测不变。该行维持跑赢行业评级，基于DCF模型，该行维持H/US股目标价34.41港元/44.24美元不变。4月11日，公司合作伙伴argenx宣布艾加莫德预充针皮下注射剂型获美国FDA批准上市。目前在国内，艾加莫德已有静脉输注和皮下注射2种给药方式，公司将于2025年在国内递交艾加莫德预充式皮下注射剂型的上市申请。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1279879.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ZLAB","09688"],"gpt_icon":1},{"id":"2527395722","title":"再鼎医药4月15日成交额为5139.17万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527395722","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527395722?lang=zh_cn&edition=full","pubTime":"2025-04-16 11:11","pubTimestamp":1744773114,"startTime":"0","endTime":"0","summary":"美东时间2025年4月15日，再鼎医药成交额为5139.17万美元，成交额较昨日减少26.43%，当日成交量为168.78万股。再鼎医药于2025年4月15日跌3.62%，报30.38美元，该股过去5个交易日涨12.23%，年初至今涨16.0%，过去60日涨16.62%。公司的专利候选药物产品管线包括 ZL-1218  实体瘤、ZL-1310  ES-SCLC 其他 NECs、ZL-6301  实体瘤、ZL6201  实体瘤。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416111202a6bc0386&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416111202a6bc0386&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK4526","BK4548","BK4139","ZLAB","BK4531","BK4588","BK4585"],"gpt_icon":1},{"id":"2527743865","title":"再鼎医药4月14日成交额为6984.99万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527743865","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527743865?lang=zh_cn&edition=full","pubTime":"2025-04-15 11:03","pubTimestamp":1744686237,"startTime":"0","endTime":"0","summary":"美东时间2025年4月14日，再鼎医药成交额为6984.99万美元，成交额较昨日减少20.44%，当日成交量为218.27万股。再鼎医药于2025年4月14日涨6.7%，报31.52美元，该股过去5个交易日涨9.41%，年初至今涨20.35%，过去60日涨24.19%。公司的专利候选药物产品管线包括 ZL-1218  实体瘤、ZL-1310  ES-SCLC 其他 NECs、ZL-6301  实体瘤、ZL6201  实体瘤。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415110404a45931ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415110404a45931ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4531","BK4548","BK4585","BK4526","BK4588","ZLAB","BK4139","LU2488822045.USD"],"gpt_icon":1},{"id":"2527147190","title":"再鼎医药上涨4.98%，报31.01美元/股，总市值34.15亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527147190","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527147190?lang=zh_cn&edition=full","pubTime":"2025-04-15 00:00","pubTimestamp":1744646405,"startTime":"0","endTime":"0","summary":"4月15日，再鼎医药盘中上涨4.98%，截至00:00，报31.01美元/股，成交4502.02万美元，总市值34.15亿美元。财务数据显示，截至2024年12月31日，再鼎医药收入总额3.99亿美元，同比增长49.59%；归母净利润-2.57亿美元，同比增长23.17%。再鼎医药的长期目标是成为全球领先的生物制药公司,以中国为基,为全球患者提供创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041500113997379d57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041500113997379d57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4585","BK4548","LU2488822045.USD","ZLAB","BK4531","BK4526","BK4588"],"gpt_icon":0},{"id":"2527768191","title":"美股异动 | 再鼎医药(ZLAB.US)涨逾8% FDA批准艾加莫德预充式皮下注射剂型","url":"https://stock-news.laohu8.com/highlight/detail?id=2527768191","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527768191?lang=zh_cn&edition=full","pubTime":"2025-04-14 22:59","pubTimestamp":1744642769,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周一，再鼎医药(ZLAB.US)盘中一度涨超13%，截至发稿，涨逾8%，报32.09美元。消息面上，4月11日，再鼎医药合作伙伴argenx公司宣布，美国食品药品监督管理局(FDA)已正式批准了艾加莫德预充式皮下注射剂型，用于治疗乙酰胆碱受体(AChR)抗体阳性的全身型重症肌无力(gMG)成人患者和慢性炎性脱髓鞘性多发性神经根神经病(CIDP)成人患者。再鼎医药表示，将于2025年在国内递交艾加莫德预充式皮下注射剂型的上市申请。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1278555.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美股异动 | 再鼎医药(ZLAB.US)涨逾8% FDA批准艾加莫德预充式皮下注射剂型","news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1588","LU2488822045.USD","BK4139","ZLAB","BK4588","09688","BK1161","BK4531","BK4548","BK1574","BK4526","BK4585"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zailaboratory.com","stockEarnings":[{"period":"1week","weight":-0.0212},{"period":"1month","weight":-0.1462},{"period":"3month","weight":0.1689},{"period":"6month","weight":0.0536},{"period":"1year","weight":0.9752},{"period":"ytd","weight":0.2157}],"compareEarnings":[{"period":"1week","weight":0.0513},{"period":"1month","weight":-0.0024},{"period":"3month","weight":-0.0789},{"period":"6month","weight":-0.0252},{"period":"1year","weight":0.0868},{"period":"ytd","weight":-0.0542}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"再鼎医药有限公司是一家主要从事生物制药的控股公司。该公司致力于通过产品的发现、开发和商业化解决肿瘤、自身免疫疾病、感染性疾病和中枢神经系统疾病领域未被满足的医疗需求。该公司拥有从发现阶段到临床项目后期的一系列专利候选药物。其中包括“则乐”、“OPTUNE”、“擎乐”、“纽再乐”及“卫伟迦”等。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.10392},{"month":2,"riseRate":0.5,"avgChangeRate":0.014818},{"month":3,"riseRate":0.25,"avgChangeRate":-0.083122},{"month":4,"riseRate":0.375,"avgChangeRate":0.008645},{"month":5,"riseRate":0.571429,"avgChangeRate":0.03934},{"month":6,"riseRate":0.428571,"avgChangeRate":0.063316},{"month":7,"riseRate":0.428571,"avgChangeRate":-0.00593},{"month":8,"riseRate":0.714286,"avgChangeRate":0.018507},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.066935},{"month":10,"riseRate":0.5,"avgChangeRate":-0.024776},{"month":11,"riseRate":0.625,"avgChangeRate":0.141461},{"month":12,"riseRate":0.5,"avgChangeRate":-0.016217}],"exchange":"NASDAQ","name":"再鼎医药","nameEN":"Zai Lab Ltd"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"再鼎医药(ZLAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供再鼎医药(ZLAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"再鼎医药,ZLAB,再鼎医药股票,再鼎医药股票老虎,再鼎医药股票老虎国际,再鼎医药行情,再鼎医药股票行情,再鼎医药股价,再鼎医药股市,再鼎医药股票价格,再鼎医药股票交易,再鼎医药股票购买,再鼎医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"再鼎医药(ZLAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供再鼎医药(ZLAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}